Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€64.50
22.03.22
-
22.03.23
-43.57%
23.03.23

Saftman 
22.03.22 50%
buy
Greenbrier Companies Inc.

Start price
Target price
Perf. (%)
€46.60
22.03.22
-
22.03.23
-37.34%
23.03.23

Saftman 
22.03.22 50%
buy
BE Semiconductor Industries N.V.

Start price
Target price
Perf. (%)
€79.50
22.03.22
-
22.03.23
-1.89%
23.03.23

Saftman 
22.03.22 50%
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€192.84
21.03.22
€200.00
21.03.23
6.90%
29.03.22

Top 10 in its market
Revenue growth >5% per year expected
Good rating
Some uniques
Traumtanz 
21.03.22 60%
sell
Netflix Inc.

Start price
Target price
Perf. (%)
€337.50
21.03.22
€310.00
21.03.23
-15.48%
21.03.23

Could be worthwhile Investment >10% per year
Justin257 
21.03.22 30%
buy
PNE AG

Start price
Target price
Perf. (%)
€9.49
21.03.22
-
21.03.25
44.78%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
21.03.22 50%
buy
Nordex SE

Start price
Target price
Perf. (%)
€15.97
21.03.22
-
21.03.25
-12.55%
09.01.23

Could be worthwhile Investment >10% per year
Lutz69 
21.03.22 50%
buy
Baader Bank AG

Start price
Target price
Perf. (%)
€5.94
21.03.22
€9.00
21.04.22
2.02%
02.04.22

Covacoro 
21.03.22 80%
buy
Faurecia S.A.

Start price
Target price
Perf. (%)
€24.62
21.03.22
-
21.03.25
-15.39%
13.06.22

Could be worthwhile Investment >10% per year
Lutz69 
21.03.22 50%
buy
Cell Impact AB

Start price
Target price
Perf. (%)
€2.06
21.03.22
-
20.06.25
-99.22%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
21.03.22 50%
buy
Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€10.25
21.03.22
-
21.03.25
-70.43%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
21.03.22 50%
buy
Nagarro SE

Start price
Target price
Perf. (%)
€147.00
21.03.22
€175.00
21.03.23
0.27%
02.04.22

Could be very worthwhile Investment >20% year
Fair valuation
Revenue growth >5% per year expected
EBIT growth >5% per year expected
skatcup 
21.03.22 80%
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€67.50
21.03.22
€75.00
21.03.23
7.41%
02.04.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
skatcup 
21.03.22 80%
buy
Authid Inc.

Start price
Target price
Perf. (%)
€32.80
21.03.22
€16.00
21.03.23
-91.02%
22.03.23

Could be worthwhile Investment >10% per year
Higher risks for its business
Risky balance sheet
tbackenh 
21.03.22 60%
buy
Alleghany Corp.

Start price
Target price
Perf. (%)
€775.00
21.03.22
€750.00
21.03.23
11.61%
05.01.23

Could be worthwhile Investment >10% per year
Good culture
Top 10 in its market
tbackenh 
21.03.22 50%
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€7.65
21.03.22
€11.00
21.03.23
-7.01%
22.03.23

Could be worthwhile Investment >10% per year
Higher risks for its business
tbackenh 
21.03.22 50%
buy
Lifeway Foods Inc.

Start price
Target price
Perf. (%)
€7.60
21.03.22
€7.00
21.03.23
-23.68%
22.03.23

Could be worthwhile Investment >10% per year
Innovative
Stable Large shareholder and/or long term investor
tbackenh 
21.03.22 50%
buy
micromobility.com Inc.

Start price
Target price
Perf. (%)
€149.00
21.03.22
-
21.03.23
1.34%
02.04.22

Good culture
Could be very worthwhile Investment >20% year
Very capable Management
Dependend from some customers or products
me8 
21.03.22 0%
sell
Mullen Automotive Inc.

Start price
Target price
Perf. (%)
€3.14
21.03.22
-
21.03.23
-13.20%
22.03.22

Could be worthwhile Investment >10% per year
zoeNEWYORK 
21.03.22 0%
sell
Ocugen Inc.

Start price
Target price
Perf. (%)
€3.65
21.03.22
€0.000
21.03.23
-19.50%
02.04.22

Higher EBIT margin than peer group
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Marianka 
21.03.22 60%
sell
Sonim Technologies Inc

Start price
Target price
Perf. (%)
€1.09
21.03.22
€0.000
21.03.23
-30.06%
02.04.22

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Revenue decline/stagnation expected
EBIT decline > 20% expected
Marianka 
21.03.22 80%
buy
PAVmed Inc

Start price
Target price
Perf. (%)
€1.35
21.03.22
€8.00
21.03.23
-14.92%
02.04.22

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
Marianka 
21.03.22 70%
sell
Sonim Technologies Inc

Start price
Target price
Perf. (%)
€1.09
21.03.22
-
21.03.23
-47.45%
22.03.23

Risky Investment
zoeNEWYORK 
21.03.22 0%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€162.42
21.03.22
€180.00
21.03.23
-2.20%
04.04.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Ellritze 
21.03.22 70%
sell
Lipocine Inc.

Start price
Target price
Perf. (%)
€25.25
21.03.22
€0.000
21.03.23
-19.90%
02.04.22

Below average Management
high free float
High risks for its business
Unknown brand
Marianka 
21.03.22 70%